"Ramipril" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.
| Descriptor ID |
D017257
|
| MeSH Number(s) |
D03.633.100.893
|
| Concept/Terms |
Triatec- Triatec
- Altace
- Zabien
- Ramace
- Tritace
- Acovil
- Delix
|
Below are MeSH descriptors whose meaning is more general than "Ramipril".
Below are MeSH descriptors whose meaning is more specific than "Ramipril".
This graph shows the total number of publications written about "Ramipril" by people in this website by year, and whether "Ramipril" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 5 | 2 | 7 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Ramipril" by people in Profiles.
-
Impact of the COVID-19 pandemic on the management of chronic heart failure. Rev Cardiovasc Med. 2021 06 30; 22(2):271-276.
-
Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model. Mol Cell Endocrinol. 2021 06 01; 529:111263.
-
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021 04; 103:106330.
-
ACE inhibitor-related angioedema in a COVID-19 patient-a plausible contribution of the viral infection? Eur J Clin Pharmacol. 2021 Jun; 77(6):933-934.
-
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19. Diabetes. 2021 03; 70(3):759-771.
-
ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19. J Am Coll Cardiol. 2020 10 27; 76(17):2041.
-
Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent? J Am Coll Cardiol. 2020 07 21; 76(3):277-279.
-
Ramipril in High-Risk Patients With COVID-19. J Am Coll Cardiol. 2020 07 21; 76(3):268-276.
-
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. Eur Heart J. 2019 07 01; 40(25):2032-2043.
-
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Eur Heart J. 2018 09 01; 39(33):3105-3114.